Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Barchart

PepsiCo Hiked Its Dividend 5% and its Yield is over 3.93% - A Buy Now for Value Investors?

PepsiCo announced a 5% dividend hike starting in June. Based on this, PEP stock has a dividend yield of over 3.93%, 42% higher than its average yield over the last five years. This makes it attractive to value investors.

Barchart

Sea Ltd - What a Wide Range of Price Targets!

Summary Sea Ltd (SE) is a top pick based on Barchart's screening for highest technical buy signals, Weighted Alpha, momentum, and Trend Seeker buy signal. Since the Trend Seeker buy signal on 1/21, Sea Ltd stock has appreciated by 10.57%. Sea Ltd operates in digital entertainment, e-commerce, and digital financial...

Barchart

Life Time Group Holdings Is on a Roll. You Might Want to Think Twice Before Jumping on the Bandwagon.

Premium fitness chain Life Time Group Holdings’ stock is on a roll, up more than 40% year-to-date. While the technical charts might suggest buying its stock, you don't want to own this company’s stock for the long haul. Here's why.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

What Did We Talk About in Last Week's Webinar on Technical Analysis?

Barchart's Senior Market Strategist John Rowland and I recently debated the role, and merits, of technical analysis.

Barchart

Dell Could Hike Its Dividend Soon - Is It Worth Buying Now?

Dell Technologies will likely announce a dividend hike with its earnings release at the end of February. If its free cash flow and FCF margins are strong, this could make DELL stock worth buying now.

Barchart

New Found Gold (NFGC): Why This Short Attack Penny Stock Has Speculators Talking

While NFGC stock is one of the riskiest mining investments available, the underlying gold concentration sampling reports warrant a closer investigation.

Barchart

3 High-Yielding Dividend Kings to Buy to Hand Over Fist

Dividend Kings, with 50+ years of growth, offer stability. Here are three top-rated, high-yield picks.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Is PayPal a Bargain Here? Its Huge Free Cash Flow Could Push PYPL Stock Higher

PayPal produced strong revenue and free cash flow in Q4, but PYPL stock has fallen since its results were released. This could provide an opportunity for value investors based on its valuation.

Barchart

Corn Prices Rebound in 2025: Is the Rally Here to Stay? Want Less Risk to Participate?

Corn markets showed signs of life in early 2025 after a tough year of price declines, creating fresh opportunities for traders. After the USDA's recent WASDE report, the supply outlook is clearer—but will demand and global factors drive a sustained rally? Volatility will increase, and the CME Group will introduce…

Barchart

Is Palantir (PLTR) Overvalued? The Empirical Data Might Surprise You.

Although it’s more than reasonable to have some skepticism toward PLTR stock, investors will want to let the facts dictate their decision-making process.

Barchart

Tariff Fears and Weather Woes: How Uncertainty is Fueling Grain Market Volatility

Market analyst Darin Newsom believes current market fluctuations are driven by news headlines and manipulation, similar to 2017-2020, and that while some technical indicators may still be relevant, the market's reaction to news, including potential tariff increases and weather concerns, creates uncertainty and volatility across various sectors, impacting investor behavior…

Barchart

Unusual Activity in GOOGL Options Highlights Alphabet's Value

A large tranche of near-term call options traded in GOOGL stock, highlighting Alphabet Inc.'s underlying value. It generated strong free cash flow in Q4, but the stock is down, providing an opportunity for value players.

Barchart

Spotify Is Spot On!

Summary Spotify Technology (SPOT) shows strong technical indicators with 100% buy signals, a 179.48% gain in the last year, and consistent price appreciation. The stock has a Trend Seeker buy signal since 1/22, resulting in a 25.98% gain, and is above its 20, 50, and 100-day moving averages. Analysts have...

Barchart

Palantir's "Eviscerating" Q4 Results (their words!) - PLTR Stock Skyrockets 25%

Palantir's Q4 results were astounding, "eviscerating" (their words in the press release) the consensus. I looked that up—it means "disemboweling." Revenue skyrocketed 36% YoY, and its FCF margin hit 63% - both disemboweling consensus estimates.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Banco Macro Is Back Moving Up the Top 100 Stocks to Buy

In September, the Argentinian bank jumped fifth in Barchart’s Top 100 Stocks to Buy. On Monday, it jumped up 14 spots to 55th. Its weighted alpha is higher than its 52-week gains, suggesting it’s on the move again.

Barchart

Verona Pharma Keeps Hitting New Highs

Summary Verona Pharma (VRNA) shows strong technical indicators with a 54.89% gain since 11/19, driven by Barchart's Trend Seeker buy signal. The company focuses on developing ensifentrine for respiratory diseases, currently in Phase 3 trials, with multiple inhaler formulations. Barchart's technical indicators highlight 100% buy signals, a 222.12% gain in...

Barchart

Silver Prices Welcome Trump's Negotiation Tactic

The recent talks of tariffs on Mexico and Canada are now a reality. The days leading up to the tariffs saw silver prices firming and volatility increasing. Markets are forward-looking mechanisms and always anticipate what the future will hold for prices. Putting tariffs on the world's largest silver producer, Mexico,…

Barchart

ExxonMobil Gushes Huge Cash Flow Albeit at Lower Levels - Is it Time to Buy?

ExxonMobil generated strong cash flow from operations and free cash flow, although both were lower than last year. XOM stock is well off its highs, reflecting this lower performance, so is it time to buy? One value measure says yes.

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

How to Approach Short-Squeeze Candidate Wolfspeed (WOLF)

Although WOLF stock presents a compelling deal on paper, investors will need to blueprint their strategies carefully.

Barchart

Chevron's Dividend Hike Shows CVX Stock is Too Cheap

Chevron Corp hiked its annual dividend by 5%, as its free cash flow was strong and positive, although lower than last year. Nevertheless, CVX is undervalued as its 4.55% yield is well over the 4.23% historical average.

Barchart

Micron Technology Stock Has Unusual Options Activity - a Bullish Signal

Today, a large tranche of out-of-the-money put options traded in Micron Technology stock. Given the recent pullback in MU stock, this is a bullish signal for investors and a good income yield play.

Barchart

Palantir Seems To Be Gathering Steam Again

Summary Palantir Technologies (PLTR) shows strong technical buy signals, with a 57% gain since 11/5 and a 390.70% gain in the last year. The company offers robust software platforms like Gotham, Foundry, Apollo, and AIP, aiding intelligence and commercial sectors in data analysis and AI. Analysts have mixed opinions: 2...

Barchart

Trump's Bump in the S&P 500 is the Side of Extreme Rarely Seen, But That's Why it's Needed

The S&P 500 continues its bull market run from the October 2023 lows. While there are claims about the market being over-extended, the bull move does not seem ready to rest. President Trump has announced numerous outside investments in the US. An optimal seasonal buy window is approaching. Technically, the…

Barchart

Beyond the Hype: Why Fiverr Is More Than an AI Victim

Although FVRR stock would seem to suffer a major headwind in the form of AI agents, the evolution of the gig economy represents an unignorable upside catalyst.

Barchart

Delcath Systems - Super Growth Projections

Summary Delcath Systems (DCTH) shows strong technical buy signals, with a 53.41% gain since 1/25 and a 271.33% gain in the last year. The company focuses on liver cancer treatments, with its leading product HEPZATO KIT and ongoing FOCUS clinical trial for metastatic uveal melanoma. Barchart indicators highlight 100% technical...

1 … 75 76 77 78

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.